These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9681411)

  • 1. Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion.
    Cherington V; Chiang GG; McGrath CA; Gaffney A; Galanopoulos T; Merrill W; Bizinkauskas CB; Hansen M; Sobolewski J; Levine PH; Greenberger JS; Hurwitz DR
    Hum Gene Ther; 1998 Jul; 9(10):1397-407. PubMed ID: 9681411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells.
    Hurwitz DR; Kirchgesser M; Merrill W; Galanopoulos T; McGrath CA; Emami S; Hansen M; Cherington V; Appel JM; Bizinkauskas CB; Brackmann HH; Levine PH; Greenberger JS
    Hum Gene Ther; 1997 Jan; 8(2):137-56. PubMed ID: 9017418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.
    Krebsbach PH; Zhang K; Malik AK; Kurachi K
    J Gene Med; 2003 Jan; 5(1):11-7. PubMed ID: 12516047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of human factor IX in retrovirus-transfected human umbilical cord tissue derived mesenchymal stem cells].
    Chen XL; Dong CL; Feng XM; Chen ZP; Zhou ZP; Xu XH; Zhao QJ; Qiu ZY; Ren Q; Zhang L; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):184-7. PubMed ID: 19236775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic modification of bone-marrow mesenchymal stem cells and hematopoietic cells with human coagulation factor IX-expressing plasmids.
    Sam MR; Azadbakhsh AS; Farokhi F; Rezazadeh K; Sam S; Zomorodipour A; Haddad-Mashadrizeh A; Delirezh N; Mokarizadeh A
    Biologicals; 2016 May; 44(3):170-7. PubMed ID: 26928674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648.
    Chiang GG; Rubin HL; Cherington V; Wang T; Sobolewski J; McGrath CA; Gaffney A; Emami S; Sarver N; Levine PH; Greenberger JS; Hurwitz DR
    Hum Gene Ther; 1999 Jan; 10(1):61-76. PubMed ID: 10022531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs.
    Zhang J; Xu L; Haskins ME; Parker Ponder K
    Blood; 2004 Jan; 103(1):143-51. PubMed ID: 12969967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Splicing and stability of intron in the expression retroviral vector with human clotting factor IX].
    Xing YN; Lu DR; Gao XB; Qiu XF; Xue JL
    Yi Chuan Xue Bao; 1998 Dec; 25(6):471-7. PubMed ID: 10465892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of biologically active human clotting factor IX in Drosophila S2 cells: γ-carboxylation of a human vitamin K-dependent protein by the insect enzyme.
    Vatandoost J; Zomorodipour A; Sadeghizadeh M; Aliyari R; Bos MH; Ataei F
    Biotechnol Prog; 2012; 28(1):45-51. PubMed ID: 22012919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent expression of canine factor IX in hemophilia B canines.
    Chao H; Samulski R; Bellinger D; Monahan P; Nichols T; Walsh C
    Gene Ther; 1999 Oct; 6(10):1695-704. PubMed ID: 10516718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors.
    Chao H; Liu Y; Rabinowitz J; Li C; Samulski RJ; Walsh CE
    Mol Ther; 2000 Dec; 2(6):619-23. PubMed ID: 11124063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B.
    Xu L; Gao C; Sands MS; Cai SR; Nichols TC; Bellinger DA; Raymer RA; McCorquodale S; Ponder KP
    Blood; 2003 May; 101(10):3924-32. PubMed ID: 12531787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
    Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
    Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
    Nathwani AC; Davidoff A; Hanawa H; Zhou JF; Vanin EF; Nienhuis AW
    Blood; 2001 Mar; 97(5):1258-65. PubMed ID: 11222368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
    Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G
    J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
    Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
    Dai YF; Qiu XF; Xue JL; Liu ZD
    Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells.
    Wen J; Vargas AG; Ofosu FA; Hortelano G
    J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro expression of hemophilia B gene mediated by lentivirus].
    Yan DM; Xu KL; Du B; Zeng LY; Lu QX; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):583-6. PubMed ID: 19175982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.